Dallah Healthcare Company — Cyborg Score 7/10

Strategic Profile

The main core business for Dallah Health is hospitals, and the company runs two hospitals. The company has investments and shares in other companies in the healthcare industry in MENA, in which Dallah health invests heavily. This diversified model across hospital operations, pharmaceuticals, and healthcare investments positions the company as an integrated regional healthcare player with exposure to the MENA healthcare ecosystem.

Cyborg Score Rationale

Dallah Healthcare demonstrates strong market positioning with a significant market capitalization and diversified business segments. The company benefits from the growing Saudi healthcare sector and has strategic healthcare investments across MENA. However, stock performance has declined approximately 19% over the past year, suggesting some operational or market headwinds.

Top Insights

• One of Dallah Healthcare's 2 competitors is Mouwasat Medical Services, a formerly PE-backed company based in Dammam, Saudi Arabia.
• Dallah Healthcare's most recent deal was a Merger/Acquisition with Al-Ahsa Medical Services on 25-Feb-2024.
• The majority of the company's revenue is earned from the Medical service segment.
• The Dallah Health dividend yield is 1.64%.

Named Competitors

• Hospital Operations & Medical Services — Private healthcare provider in Dammam competing in hospital and medical services

Recent Developments

• (February 2024) Acquisition of Al-Ahsa Medical Services
• (December 2025) Trading near 122 SAR with recent technical weakness
• (March 2026) Scheduled earnings release on March 24, 2026

Open the full interactive Dallah Healthcare Company report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.